172 related articles for article (PubMed ID: 36296228)
1. First Detection of the SARS-CoV-2 Omicron BA.5/22B in Monaco.
Colson P; Lavagna C; Delerce J; Groshenry G; Yahi N; Fantini J; La Scola B; Althaus T
Microorganisms; 2022 Sep; 10(10):. PubMed ID: 36296228
[TBL] [Abstract][Full Text] [Related]
2. Mutational Analysis of Circulating Omicron SARS-CoV-2 Lineages in the Al-Baha Region of Saudi Arabia.
Almalki SSR; Izhari MA; Alyahyawi HE; Alatawi SK; Klufah F; Ahmed WAM; Alharbi R
J Multidiscip Healthc; 2023; 16():2117-2136. PubMed ID: 37529147
[TBL] [Abstract][Full Text] [Related]
3. Mutational characterization of Omicron SARS-CoV-2 lineages circulating in Chhattisgarh, a central state of India.
Singh P; Sharma K; Shaw D; Bhargava A; Negi SS
Front Med (Lausanne); 2022; 9():1082846. PubMed ID: 36755883
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 Co-Infections and Recombinations Identified by Long-Read Single-Molecule Real-Time Sequencing.
Trémeaux P; Latour J; Ranger N; Ferrer V; Harter A; Carcenac R; Boyer P; Demmou S; Nicot F; Raymond S; Izopet J
Microbiol Spectr; 2023 Aug; 11(4):e0049323. PubMed ID: 37260377
[TBL] [Abstract][Full Text] [Related]
5. First cases of infection with the 21L/BA.2 Omicron variant in Marseille, France.
Colson P; Delerce J; Beye M; Levasseur A; Boschi C; Houhamdi L; Tissot-Dupont H; Yahi N; Million M; La Scola B; Fantini J; Raoult D; Fournier PE
J Med Virol; 2022 Jul; 94(7):3421-3430. PubMed ID: 35243660
[TBL] [Abstract][Full Text] [Related]
6. Molecular evolution of SARS-CoV-2 from December 2019 to August 2022.
Wolf JM; Wolf LM; Bello GL; Maccari JG; Nasi LA
J Med Virol; 2023 Jan; 95(1):e28366. PubMed ID: 36458547
[TBL] [Abstract][Full Text] [Related]
7. A 21L/BA.2-21K/BA.1 "MixOmicron" SARS-CoV-2 hybrid undetected by qPCR that screen for variant in routine diagnosis.
Colson P; Delerce J; Marion-Paris E; Lagier JC; Levasseur A; Fournier PE; La Scola B; Raoult D
Infect Genet Evol; 2022 Nov; 105():105360. PubMed ID: 36070806
[TBL] [Abstract][Full Text] [Related]
8. Unique mutations in SARS-CoV-2 Omicron subvariants' non-spike proteins: Potential impacts on viral pathogenesis and host immune evasion.
Hossain A; Akter S; Rashid AA; Khair S; Alam ASMRU
Microb Pathog; 2022 Sep; 170():105699. PubMed ID: 35944840
[TBL] [Abstract][Full Text] [Related]
9. Evolution of the SARS-CoV-2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission.
Shrestha LB; Foster C; Rawlinson W; Tedla N; Bull RA
Rev Med Virol; 2022 Sep; 32(5):e2381. PubMed ID: 35856385
[TBL] [Abstract][Full Text] [Related]
10. Disappearance of Imported Cases of Omicron Lineage BA.2.40 in West Kalimantan, Indonesia.
Liana DF; Novianry V; Andriani A; Mahyarudin M; Astuti P
Iran J Med Sci; 2024 Mar; 49(3):176-185. PubMed ID: 38584647
[TBL] [Abstract][Full Text] [Related]
11. The First Identification in Italy of SARS-CoV-2 Omicron BA.4 Harboring KSF141_del: A Genomic Comparison with Omicron Sub-Variants.
Peronace C; Tallerico R; Colosimo M; Fazio M; Pasceri F; Talotta I; Panduri G; Pintomalli L; Oteri R; Calantoni V; Fiorillo MT; Caroleo MC; Curcio R; Dolce V; Cione E; Minchella P
Biomedicines; 2022 Jul; 10(8):. PubMed ID: 36009386
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of the First 284 Patients Infected with the SARS-CoV-2 Omicron BA.2 Subvariant at a Single Center in the Apulia Region of Italy, January-March 2022.
Loconsole D; Centrone F; Sallustio A; Accogli M; Casulli D; Sacco D; Zagaria R; Morcavallo C; Chironna M
Vaccines (Basel); 2022 Apr; 10(5):. PubMed ID: 35632430
[TBL] [Abstract][Full Text] [Related]
13. Tracking SARS-CoV-2 Omicron diverse spike gene mutations identifies multiple inter-variant recombination events.
Ou J; Lan W; Wu X; Zhao T; Duan B; Yang P; Ren Y; Quan L; Zhao W; Seto D; Chodosh J; Luo Z; Wu J; Zhang Q
Signal Transduct Target Ther; 2022 Apr; 7(1):138. PubMed ID: 35474215
[TBL] [Abstract][Full Text] [Related]
14. Detection of SARS-CoV-2 VOC-Omicron using commercial sample-to-answer real-time RT-PCR platforms and melting curve-based SNP assays.
Sit BHM; Po KHL; Cheung YY; Tsang AKL; Leung PKL; Zheng J; Lam AYT; Lam ETK; Ng KHL; Chan RCW
J Clin Virol Plus; 2022 Aug; 2(3):100091. PubMed ID: 35761832
[TBL] [Abstract][Full Text] [Related]
15. Genome sequence diversity of SARS-CoV-2 in Serbia: insights gained from a 3-year pandemic study.
Novkovic M; Banovic Djeri B; Ristivojevic B; Knezevic A; Jankovic M; Tanasic V; Radojicic V; Keckarevic D; Vidanovic D; Tesovic B; Skakic A; Tolinacki M; Moric I; Djordjevic V
Front Microbiol; 2024; 15():1332276. PubMed ID: 38476954
[TBL] [Abstract][Full Text] [Related]
16. A tool for the cheap and rapid screening of SARS-CoV-2 variants of concern (VoCs) by Sanger sequencing.
Burgos G; Ambuludí A; ; Morales-Jadán D; Garcia-Bereguiain MA; Muslin C; Armijos-Jaramillo V
Microbiol Spectr; 2023 Sep; 11(5):e0506422. PubMed ID: 37676038
[TBL] [Abstract][Full Text] [Related]
17. Genomic Surveillance and Mutation Analysis of SARS-CoV-2 Variants among Patients in Saudi Arabia.
Alsuwairi FA; Alsaleh AN; Obeid DA; Al-Qahtani AA; Almaghrabi RS; Alahideb BM; AlAbdulkareem MA; Alsanea MS; Alharbi LA; Althawadi SI; Altamimi SA; Alshukairi AN; Alhamlan FS
Microorganisms; 2024 Feb; 12(3):. PubMed ID: 38543518
[TBL] [Abstract][Full Text] [Related]
18. Discrimination of SARS-CoV-2 Omicron Sublineages BA.1 and BA.2 Using a High-Resolution Melting-Based Assay: a Pilot Study.
Aoki A; Adachi H; Mori Y; Ito M; Sato K; Okuda K; Sakakibara T; Okamoto Y; Jinno H
Microbiol Spectr; 2022 Aug; 10(4):e0136722. PubMed ID: 35861527
[TBL] [Abstract][Full Text] [Related]
19. Identification of SARS-CoV-2 Omicron variant using spike gene target failure and genotyping assays, Gauteng, South Africa, 2021.
Subramoney K; Mtileni N; Bharuthram A; Davis A; Kalenga B; Rikhotso M; Maphahlele M; Giandhari J; Naidoo Y; Pillay S; Ramphal U; Ramphal Y; Tegally H; Wilkinson E; Mohale T; Ismail A; Mashishi B; Mbenenge N; de Oliveira T; Makatini Z; Fielding BC; Treurnicht FK;
J Med Virol; 2022 Aug; 94(8):3676-3684. PubMed ID: 35441368
[TBL] [Abstract][Full Text] [Related]
20. Multiplex RT Real-Time PCR Based on Target Failure to Detect and Identify Different Variants of SARS-CoV-2: A Feasible Method That Can Be Applied in Clinical Laboratories.
Pham VH; Pham HT; Balzanelli MG; Distratis P; Lazzaro R; Nguyen QV; Tran VQ; Tran DK; Phan LD; Pham SM; Pham BT; Duc CV; Nguyen HM; Nguyen DNT; Tran NV; Pham ST; Queck C; Nguyen KDC; Inchingolo F; Del Prete R; Nguyen NHD; Santacroce L; Gargiulo Isacco C
Diagnostics (Basel); 2023 Apr; 13(8):. PubMed ID: 37189465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
